.

Deeper Knowledge, Faster

  • Anticipate your formulary budget
  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Dow
Medtronic
US Department of Justice
McKinsey
Chinese Patent Office
UBS
Cerilliant
US Army
Moodys

Generated: June 23, 2017

DrugPatentWatch Database Preview

VITAPED Drug Profile

« Back to Dashboard

What is the patent landscape for Vitaped, and when can generic versions of Vitaped launch?

Vitaped is a drug marketed by Hospira and is included in one NDA.

The generic ingredient in VITAPED is ascorbic acid; biotin; cyanocobalamin; ergocalciferol; folic acid; niacinamide; pantothenic acid; phytonadione; pyridoxine; riboflavin; thiamine; vitamin a palmitate; vitamin e. There are six drug master file entries for this compound. Additional details are available on the ascorbic acid; biotin; cyanocobalamin; ergocalciferol; folic acid; niacinamide; pantothenic acid; phytonadione; pyridoxine; riboflavin; thiamine; vitamin a palmitate; vitamin e profile page.

Summary for Tradename: VITAPED

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list76
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VITAPED at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira
VITAPED
ascorbic acid; biotin; cyanocobalamin; ergocalciferol; folic acid; niacinamide; pantothenic acid; phytonadione; pyridoxine; riboflavin; thiamine; vitamin a palmitate; vitamin e
INJECTABLE;INJECTION020176-001Dec 29, 1993DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Citi
McKinsey
UBS
Fish and Richardson
Cantor Fitzgerald
Dow
US Department of Justice
Deloitte
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot